We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Anthera Pharmaceuticals Inc (CE) | USOTC:ANTH | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
Delaware
|
001-34637
|
20-1852016
|
||
(State or Other Jurisdiction of
Incorporation) |
(Commission File Number)
|
(I.R.S. Employer
Identification No.) |
25801 Industrial Boulevard, Suite B, Hayward,
California
|
94545
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Item 2.02 |
Results of Operations and Financial Conditions.
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
||
99.1
|
Press Release dated August 9, 2017
|
Date: August 9, 2017
|
Anthera Pharmaceuticals, Inc.
|
||
By:
|
/s/
May Liu
|
||
May Liu
Senior Vice President, Finance and
Administration
(Principal Accounting Officer)
|
1 Year Anthera Pharmaceuticals (CE) Chart |
1 Month Anthera Pharmaceuticals (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions